WO2003017784A1 - Composition nutraceutique a base d'herbes destinee aux femmes/femmes enceintes et son procede de preparation - Google Patents
Composition nutraceutique a base d'herbes destinee aux femmes/femmes enceintes et son procede de preparation Download PDFInfo
- Publication number
- WO2003017784A1 WO2003017784A1 PCT/IN2001/000151 IN0100151W WO03017784A1 WO 2003017784 A1 WO2003017784 A1 WO 2003017784A1 IN 0100151 W IN0100151 W IN 0100151W WO 03017784 A1 WO03017784 A1 WO 03017784A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ranging
- powder
- plants
- herbs
- seed
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 124
- 239000002417 nutraceutical Substances 0.000 title claims abstract description 70
- 235000021436 nutraceutical agent Nutrition 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims abstract description 44
- 230000008569 process Effects 0.000 title claims abstract description 40
- 238000009472 formulation Methods 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims description 13
- 241000196324 Embryophyta Species 0.000 claims abstract description 132
- 235000008216 herbs Nutrition 0.000 claims abstract description 62
- 239000000284 extract Substances 0.000 claims abstract description 60
- 230000036541 health Effects 0.000 claims abstract description 45
- 235000021374 legumes Nutrition 0.000 claims abstract description 32
- 230000001681 protective effect Effects 0.000 claims abstract description 30
- 235000013339 cereals Nutrition 0.000 claims abstract description 27
- 230000001737 promoting effect Effects 0.000 claims abstract description 26
- 235000001978 Withania somnifera Nutrition 0.000 claims abstract description 21
- 240000004482 Withania somnifera Species 0.000 claims abstract description 21
- 241000167550 Centella Species 0.000 claims abstract description 16
- 241000755726 Chlorophytum Species 0.000 claims abstract description 15
- 241000826711 Pueraria tuberosa Species 0.000 claims abstract description 10
- 244000170475 Saraca indica Species 0.000 claims abstract description 10
- SASUFNRGCZMRFD-JCUIILOWSA-N withanolide D Chemical compound C1C(C)=C(C)C(=O)O[C@H]1[C@](C)(O)[C@@H]1[C@@]2(C)CC[C@@H]3[C@@]4(C)C(=O)C=C[C@H](O)[C@@]54O[C@@H]5C[C@H]3[C@@H]2CC1 SASUFNRGCZMRFD-JCUIILOWSA-N 0.000 claims abstract description 9
- 235000016135 Saraca indica Nutrition 0.000 claims abstract description 8
- 241000432811 Asparagus racemosus Species 0.000 claims abstract 3
- 239000000843 powder Substances 0.000 claims description 128
- 239000000047 product Substances 0.000 claims description 43
- 235000013399 edible fruits Nutrition 0.000 claims description 28
- 235000000346 sugar Nutrition 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 235000013336 milk Nutrition 0.000 claims description 17
- 239000008267 milk Substances 0.000 claims description 17
- 210000004080 milk Anatomy 0.000 claims description 17
- 235000019510 Long pepper Nutrition 0.000 claims description 16
- 240000003455 Piper longum Species 0.000 claims description 16
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 15
- 235000010469 Glycine max Nutrition 0.000 claims description 14
- 244000068988 Glycine max Species 0.000 claims description 14
- 235000015872 dietary supplement Nutrition 0.000 claims description 14
- 239000012674 herbal formulation Substances 0.000 claims description 14
- 241000222666 Boerhavia diffusa Species 0.000 claims description 13
- 240000006890 Erythroxylum coca Species 0.000 claims description 13
- 244000191761 Sida cordifolia Species 0.000 claims description 13
- 240000004922 Vigna radiata Species 0.000 claims description 13
- 235000008957 cocaer Nutrition 0.000 claims description 13
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims description 13
- 235000011746 Amaranthus hypochondriacus Nutrition 0.000 claims description 12
- 240000003147 Amaranthus hypochondriacus Species 0.000 claims description 12
- 240000005979 Hordeum vulgare Species 0.000 claims description 12
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 12
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 12
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 11
- 238000011161 development Methods 0.000 claims description 11
- 235000009421 Myristica fragrans Nutrition 0.000 claims description 10
- 244000270834 Myristica fragrans Species 0.000 claims description 10
- 235000015097 nutrients Nutrition 0.000 claims description 10
- 235000004032 Centella asiatica Nutrition 0.000 claims description 9
- 244000146462 Centella asiatica Species 0.000 claims description 9
- 241001657236 Chlorophytum tuberosum Species 0.000 claims description 9
- 235000010523 Cicer arietinum Nutrition 0.000 claims description 9
- 244000045195 Cicer arietinum Species 0.000 claims description 9
- 241001510312 Elettaria Species 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 241000498779 Myristica Species 0.000 claims description 9
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 8
- 240000002943 Elettaria cardamomum Species 0.000 claims description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 8
- 241000219780 Pueraria Species 0.000 claims description 8
- 244000098338 Triticum aestivum Species 0.000 claims description 8
- 235000006085 Vigna mungo var mungo Nutrition 0.000 claims description 8
- 241000219312 Chenopodium Species 0.000 claims description 7
- 240000006162 Chenopodium quinoa Species 0.000 claims description 7
- 235000018602 Elettaria cardamomum Nutrition 0.000 claims description 7
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 claims description 7
- 244000046095 Psophocarpus tetragonolobus Species 0.000 claims description 7
- 241000209140 Triticum Species 0.000 claims description 7
- 235000021307 Triticum Nutrition 0.000 claims description 7
- 239000000654 additive Substances 0.000 claims description 7
- 239000007795 chemical reaction product Substances 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 239000000725 suspension Substances 0.000 claims description 7
- 235000015493 Chenopodium quinoa Nutrition 0.000 claims description 6
- 235000006161 Mucuna pruriens Nutrition 0.000 claims description 6
- 244000111261 Mucuna pruriens Species 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- 230000012010 growth Effects 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 5
- 241000219318 Amaranthus Species 0.000 claims description 4
- 241000220455 Cicer Species 0.000 claims description 4
- 235000010521 Cicer Nutrition 0.000 claims description 4
- 239000004471 Glycine Substances 0.000 claims description 4
- 241000122904 Mucuna Species 0.000 claims description 4
- 241000219833 Phaseolus Species 0.000 claims description 4
- 235000014465 Psophocarpus palustris Nutrition 0.000 claims description 4
- 244000279064 Psophocarpus palustris Species 0.000 claims description 4
- 235000015895 biscuits Nutrition 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 241000209219 Hordeum Species 0.000 claims description 3
- 241000722363 Piper Species 0.000 claims description 3
- 241000350490 Saraca Species 0.000 claims description 3
- 239000001567 elettaria cardamomum seed Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 240000008620 Fagopyrum esculentum Species 0.000 claims 3
- 244000039141 Phaseolus mungo Species 0.000 claims 2
- 244000193174 agave Species 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000013305 food Nutrition 0.000 description 32
- 239000004615 ingredient Substances 0.000 description 17
- 235000016709 nutrition Nutrition 0.000 description 14
- 241000219051 Fagopyrum Species 0.000 description 12
- 230000003449 preventive effect Effects 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 230000035764 nutrition Effects 0.000 description 11
- 241000472349 Asparagus adscendens Species 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 235000019155 vitamin A Nutrition 0.000 description 8
- 239000011719 vitamin A Substances 0.000 description 8
- 229940045997 vitamin a Drugs 0.000 description 8
- 241000234427 Asparagus Species 0.000 description 7
- 208000002720 Malnutrition Diseases 0.000 description 7
- 244000042295 Vigna mungo Species 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 239000002934 diuretic Substances 0.000 description 6
- 230000001882 diuretic effect Effects 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 235000000824 malnutrition Nutrition 0.000 description 6
- 230000001071 malnutrition Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 208000015380 nutritional deficiency disease Diseases 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-M L-ascorbate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CIWBSHSKHKDKBQ-JLAZNSOCSA-M 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 235000013376 functional food Nutrition 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- 235000015418 Bacopa monnieria Nutrition 0.000 description 4
- 244000187129 Bacopa monnieria Species 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- 239000009405 Ashwagandha Substances 0.000 description 3
- 229920002774 Maltodextrin Polymers 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 3
- 229940014662 pantothenate Drugs 0.000 description 3
- 239000011713 pantothenic acid Substances 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 235000017807 phytochemicals Nutrition 0.000 description 3
- 229940068065 phytosterols Drugs 0.000 description 3
- 229930000223 plant secondary metabolite Natural products 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- DBRXOUCRJQVYJQ-CKNDUULBSA-N withaferin A Chemical compound C([C@@H]1[C@H]([C@@H]2[C@]3(CC[C@@H]4[C@@]5(C)C(=O)C=C[C@H](O)[C@@]65O[C@@H]6C[C@H]4[C@@H]3CC2)C)C)C(C)=C(CO)C(=O)O1 DBRXOUCRJQVYJQ-CKNDUULBSA-N 0.000 description 3
- 235000006760 Acer pensylvanicum Nutrition 0.000 description 2
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 2
- 240000001592 Amaranthus caudatus Species 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- 235000003351 Brassica cretica Nutrition 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 235000003343 Brassica rupestris Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 239000004384 Neotame Substances 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 235000010716 Vigna mungo Nutrition 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000004178 amaranth Substances 0.000 description 2
- 235000012735 amaranth Nutrition 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000003048 aphrodisiac agent Substances 0.000 description 2
- 230000002509 aphrodisiac effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 2
- 230000004641 brain development Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 229940046381 choline 65 mg Drugs 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000002955 immunomodulating agent Substances 0.000 description 2
- 230000002584 immunomodulator Effects 0.000 description 2
- 229940121354 immunomodulator Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000010460 mustard Nutrition 0.000 description 2
- 235000019412 neotame Nutrition 0.000 description 2
- 108010070257 neotame Proteins 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- GWNBMLCISLLOAU-UHFFFAOYSA-N 4-oxo-2-phenylchromene-3-carbaldehyde Chemical class O1C2=CC=CC=C2C(=O)C(C=O)=C1C1=CC=CC=C1 GWNBMLCISLLOAU-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001280436 Allium schoenoprasum Species 0.000 description 1
- 235000001270 Allium sibiricum Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034308 Grand mal convulsion Diseases 0.000 description 1
- 241001091440 Grossulariaceae Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 150000000994 L-ascorbates Chemical class 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710188314 Protein V Proteins 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 235000002357 Ribes grossularia Nutrition 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000271897 Viperidae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WVEXRFDJWLAXJU-UHFFFAOYSA-N [Ca].[Ca].[Ca].[Ca] Chemical compound [Ca].[Ca].[Ca].[Ca] WVEXRFDJWLAXJU-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000002592 antimutagenic agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037208 balanced nutrition Effects 0.000 description 1
- 235000019046 balanced nutrition Nutrition 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940085298 biotin 10 mg Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000008370 chocolate flavor Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000005467 galactogogue Substances 0.000 description 1
- 230000001752 galactogogue Effects 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 150000002630 limonoids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229940088154 niacinamide 15 mg Drugs 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- -1 phytosterols Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000003784 poor nutrition Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Definitions
- the present invention relates to an herbal health protective and promotive nutraceutical formulations for females / expectant mothers.
- Nutraceuticals are foods or bioactive ingredients in foods that protect or promote health whether delivered in raw agricultural commodities, processed foods, dietary supplements, extracts, beverages or other products and occurs at the intersection of food and pharmaceutical industries.
- Nutraceuticals have potential to be used as food supplement, preventive medicine and the growing evidence points in the direction that certain foods fight and or prevent against diseases.
- the food may be nutraceutical i.e. a food or parts of food that provide medical health benefits including the prevention and or treatment of diseases.
- Functional foods provide specific benefits, and medical foods developed for use under medical supervision to treat or manage particular disease or nutritional deficiency stage.
- Nutraceutical and functional- foods are a hybrid of both the traditionally defined food and drug arenas.
- the word Nutraceuticals combines 'nutrition' and 'pharmaceuticals' to mean that food can be used as preventive drugs or food supplements.
- the entire concept is based on the disease preventing phytonutrients present in foodstuffs of the diet in combating diseases.
- the major phytonutrients identified to have nutraceutical properties include terpenes, phytosterols, phenols and theols.
- Carotenoids found in green leafy vegetables like amaranth, Chenopodium (goose foot), mustard, 'Methi', spinach and cabbage etc are precursor of vitamin A. They have preventive action against many eye diseases, cancer and also acts as antioxidant. Limonoids also acts as antioxidants by protecting lung tissues from oxygen free radicals. Antioxidants have been associated with reduced risk of cardiovascular diseases and several types of cancer. They are known to act to defuse the volatile toxic molecules of free oxygen radicals, a by-product of cell metabolism. These are also produced in the body on exposure to sunlight, X-rays, ozone, tobacco smoke, auto-exhaust and other environmental pollutants.
- Carotenoids, tocopherols, ascorbates and polyphenols are strong natural antioxidants generally found in plants and foods. They enhance the body's detoxification activity and protect against certain type of cancers by eliminating ill health causing chemical from the body to prevent degenerative diseases.
- Phytosterols competes with dietary cholesterol for uptake in intestine thereby blocking cholesterol absorption into the body and can also prevent the development of tumor in breast and prostate glands.
- Phenols a large group of phytonutrients, with sub classes in flavonoids, biflavonoids, anthocyanines and isoflavonoids have profound importance in preventive medicine. Berries, grapes and eggplants are rich in phenolics and have protective action against oxidative damage of tissues and inflammation.
- phytochemicals can enhance the efficacy of vitamin C, can also act against allergies, ulcers, tumors, platelet aggregation, controlling hypertension and can reduce the risk of estrogen induced cancer.
- Anthocyanidines or flavonals have significant role in collagen protein synthesis and are important in sports medicine. Beans and other legumes are rich natural sources of protein with the necessary nutrients needed for a healthy body and many of them contain specific immune- boosting potential.
- Theols are major sulfur containing phytonutrients and the nutraceutical foods rich in theols include garlic, onion, mustard, cabbage, turnip and chives. They are potent antimutagenic and anticarcinogenic agents and gives cardio vascular protection.
- Cruciferous vegetables are rich source of glucosinolates, which activate liver detoxification enzymes and can reduce tumor. They can also block the activity of toxins produced by bacteria and viruses thereby building immunity against diseases. Indoles found in citrus and gooseberries are effective against carcinogenic chemicals in the intestine.
- the herbs like alfalfa, Ginko biloba, Ginseng, St John's wort etc are considered to be good for brain development.
- Malnutrition is a major problem in the developing and third world countries resulting several diseases and low IQ in children.
- a child's capacity to learn is directly related to food intake and good nutrition (Child Nutrition Advisory Council, USA).
- the development of brain mainly depends on the health of pregnant and lactating mother finally on the quality of mother's diet.
- the food also plays significant role in the general health of infants, growing children, diabetics, heart, nerves and aged.
- the right foods do have the power to heal, keeping good health of body functions, ageing, rejuvenating, immuno-modulating and prevention against diseases, just as the wrong foods can cause sickness, rapid ageing and premature death.
- the environmental and dietary factors i.e. poor nutrition habits are one of the co-factors for different diseases.
- To combat malnutrition and growing demand of nutraceuticals need tailoring practices through value addition to optimize the concentration and bioavailability of the desired food
- soybean (Glycine max), kidney-bean (Phaseolus vulgaris), chick-pea (Cicer arietinum), black-gra /'Urd' (Phaseolus mungo), green-gram/'Mung' (Phaseolus radiatus), winged bean (Psophocarpus tetragonolobus), 'Kewanch' (Mucuna pruriens), wheat (Triticum aestivum) barley (Hordeum vulgare), amaranth (Amaranthus hypochondriacus), goose foot/quinoa (Chenopodium quinoa) and buckwheat (Fagopyrum esculantus) have been described.
- nutraceuticals and ingredients for functional foods are prepared by co- spray drying using fructans, fructooligosaccharides instead of maltodextrins as a drying agent and ingredients such as flavonoids, anthocyanins, resveratrol.
- the main emphasis has been limited to phenolic phytochemicals and products are in the form of a gel or cream, showing fat like texture which can only be used as spreader. Reference is made to patents (Patent No.
- nutraceuticals comprising a blend of N-[N-(3,3- dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 1-methyl ester (neotame) with another sweetener has been mentioned.
- the compounds used are synthetic and have limited importance only as sweetener or flavor modifier in nutraceuticals.
- Neotame is a synthetic variation of aspartame and poses potential major health problems like incidents of grand mal seizures, brain tumors and environmental hazards. Reference is made to patents (Patent No.
- nutracuticals with branded name as Dieter's Formula, Digestive Formula, Mega Man, Stress formula, vegetative Laxative, Memory helper with Ginko biloba, Revitalizer with Ginseng, Dieter's helper etc are available in international market (Internet).
- Boost Horlics, Bounrvita, Cerelac, Protinex, Body Pro, Mega Mass, Muscle Builder, 90 Plus Protein and Soyatein etc are available.
- Boost Horlics
- Bounrvita Cerelac
- Protinex Body Pro
- Mega Mass Muscle Builder
- 90 Plus Protein and Soyatein etc are available.
- natural ingredients majority of the products also contain some synthetic amino acids, vitamins and other ingredients. Most of them are without any natural herbs/medicinal plants and recommended as food supplement for nutrition.
- the present invention provides a process for the preparation of nutraceuticals with specific combination of edible legumes, cereals, pseudocereals for natural nutrients and herbs/medicinal plants with significant medicinal values to provide optimum balanced nutrition and general health protective, preventive and promotive benefits.
- any process for nutraceutical preparation does not exist comprising a combination of legumes, cereals, pseudocereals fortified with herbs/ medicinal plants used in the present investigation.
- nutraceuticals comprising a proper combination of natural edible seeds, herbs and medicinal plants has not yet been prepared to provide adequate nutrition and health protective benefits.
- the main object of the present invention relates to the custom made tailored nutraceutical functional food composition(s), in a proper combination of natural edible seeds, herbs/ medicinal plants to provide optimum nutrition, health protective, preventive and promotive benefits for general health care of the females, pregnant and lactating mothers and to ward off malnutrition.
- Another object of the present invention is to provide an herbal health protective nutraceutical formulation, which obviates the drawbacks as detailed above.
- Yet another object of the present invention is to provide nutraceutical formulation for optimum nutrition, general health promotive and well being of the females to ameliorate the general health at prenatal and post natal stages and to ward off malnutrition.
- the present invention relates to the custom made tailored nutraceutical functional food composition(s), in a proper combination of natural edible seeds, herbs/ medicinal plants to provide optimum nutrition, health protective, preventive and promotive benefits for general health care of the women, pregnant and lactating mothers and to ward off malnutrition.
- the present invention provides a herbal health protective, promotive neutraceutical formulation for women/expectant human mothers, said formulation comprising seeds/seed products selected from the group consisting of legumes, cereals and pseudocereals ranging from 80-90% and an extract ranging between 10-20%.
- the present invention provides a composition used as a herbal health protective, promotive neutraceutical formulation for females/expectant mothers, said composition comprising the said formulation consisting of seed powder mixture herbs/medicinal plant extract, and the composition further comprising sugar/jaggary , milk powder, Piper longum fruits, Myristica fragrans fruit powder, Elettaria cardamomum seed powder and coca powder.
- the present invention also provide a process for the preparation of custom made herbal health protective, promotive nutraceutical formulations which may be used as food supplements to ameliorate the general health of females with optimum nutrients so as to ensure the optimal growth and development of the child both at prenatal and post natal stages.
- the process comprises the seeds, from selected genera of Glycine, Phaseolus, Cicer, Psophocarpus, Mucuna, Triticum, Hordeum, Amaranthus, Chenopodium and Fagopyrum, may be roasted by keeping in microwave oven (BPL-Sanyo, model BMO 800 TS, frequency 2450 Mhz) ranging from 2 to 15 minutes separately, the microwave roasted seeds, 12 in number, may be powdered separately to pass through a sieve ranging from 50 to 400- mesh, the seed powders may be mixed ranging from 0 to 75% to get the base products, in a mixer grinder ranging from 5 to 55 minutes and may be called as base product, the roots, fruits, bark, whole plant of natural authentic herbs/medicinal plants from the genera of Centella, Withania, Pueraria, Asparagus, Chlorophytum, Boerhaavia, Sida, Saraca, Piper, Elettaria and Myristica may be collected from different natural sources in India and may be cut into small pieces 2
- the combination of the present nutraceuticals is not a mere admixture of the ingredients used resulting in aggregation of their properties but a mixture having synergistically enhanced properties useful as food supplement for health protective, preventive and promotive benefits of the females, pregnant and lactating mothers including pre and post natal stages.
- the said formulation comprising seeds/ seed products selected from the group consisting of legumes, cereals and pseudocereals ranging from 80-90% by wt; 10 - 20 % by wt of extract obtained from essential herbs/ medicinal plants of the genera Centella, Chlorophytum, Boerhaavia and Sida, and optional herbs / medicinal plants selected from the Withania somnifera, Pueraria tuberosa, Asparagus racemosus and Saraca indica.
- the seeds/ seed products are selected from dried seeds, roasted seeds and powdered seeds.
- the legumes used are essentially selected from the group comprising Glycine max, Cicer arietinum, Phaseolus mungo, Phaseolus vulgaris and
- Phaseolus radiatus and optionally selected from the group comprising Psophocarpus tetragonolobus and Mucuna pruriens.
- the total amount of legumes used in the formulation is ranging from 55 - 60 % by wt.
- the cereals used are selected from Triticum aestivum, Hordeum vulgare or mixtures thereof.
- pseudocereals used are selected from
- the total amount of cereals used is in the range between 15-25 % by wt.
- the total amount of pseudocereal used is in the range between 20 - 30 % by wt.
- the said herbs/medicinal plant parts used is selected from roots, fruits, bark and whole plants.
- the total amount of herbs/medicinal plants used is X, wherein X is ranging between 10 - 20 % by wt of the formulation.
- Yet another embodiment of the invention relates to the amounts of the essential herbs/medicinal plants namely Centella asiatica, Chlorophytum tuberosum, Boerhaavia diffusa and Sida cordifolia are used in the ranges between 10-40 % by wt of X, 2-20% by wt of X, 5-30 % by wt of X and 10-20 % by wt of X respectively.
- the amounts of the essential herbs/medicinal plants namely Centella asiatica, Chlorophytum tuberosum, Boerhaavia diffusa and Sida cordifolia are used in the ranges between 16-32 % by wt of X, 4-16% by wt of X , 5-24 % by wt of X and 12-16 % by wt of X respectively.
- the amount of the optional herbs/medicinal plants namely Withania somnifera, Pueraria tuberosa, Asparagus racemosus and Saraca indica are used in the ranges between 0-16 % by wt of X, 0-24 % by wt of X and 0-16 % by wt of X and 0- 12 % by wt of X respecti vel y .
- the said herbal formulation optionally contains acceptable amount of further additives selected from Piper, Elettaria and Myristica.
- One more embodiment of the invention relates to a herbal health protective, promotive and nutraceutical composition for females and expectant mothers, wherein the said formulation comprising of seed powder mixture ranging from 44 to 52 %, herbs/medicinal plant extract ranging from 5 to 13 %, sugar/jaggary ranging form 20 to 35 %, milk powder ranging from 0 to 20%, Piper longum fruit powder ranging from 0.5 to 5.0%, Myristica fragrans fruit powder ranging from 0 to 5.0%, Elettaria cardamomum seed powder ranging from 0 to 4.0%, coca powder ranging from 0 tolO %.
- the seed powder mixture contain legumes in the range between 23-31%, cereals in the range between 6- 17% and psuedocereals in the range between 10- 13%.
- the end-product is suitable for use in the form of powder, granules, biscuits, tablets, capsules or any other suitable forms.
- One more embodiment of the invention relates to a process for the preparation of herbal health protective, promotive nutraceutical compositions useful as food supplements to ameliorate the general health of females/ expectant mothers with optimum nutrients so as to ensure the optimal growth and development of the child both at pre-natal and post-natal stages, said process comprising: a.
- seeds/seed products from the group consisting of legumes, cereals and pseudocerels wherein, the legumes consisting plants of genera Glycine, Cicer, Phaseolus, Psophocarpus, Mucuna, P.vulgaris, and P. radiatus, cereals consisting plants of genera Triticum and Hordeum, and, pseudocereals consisting plants of genera Amaranthus Chenopodium and Fagopyrum, b. roasting the seeds/seed products for 2 to 15 minutes under microwave conditions having frequency 1500-2500 Mhz, c. powdering the roasted seeds to a mesh size of 50 - 400 and mixing the same to obtain a base product, d. obtaining extract of herbs/medicinal plants from one or more plants of genera
- the roasted seed powders are mixed in various proportions ranging up to 80% and the plant parts used are selected from roots, fruits, bark and whole plant of herbs/medicinal plants ranging up to 20% are selected for use in the nutraceutical products.
- the herbs/medicinal plants are cut into small pieces ranging from 2 to 10 cm, dried under shade at the temperature ranging from 25 to 45°C and crushed to coarse powder ranging from 10 to 20 mesh size before extraction and the crushed and powdered herbs/medicinal plants are mixed up to 50% of the total mixture.
- the powdered herbs/medicinal plants mixture is extracted with aqueous alcohol in the range of 10 to 90% v/v thrice for 12 to 48 hours, at temperature ranging from 25 to 45°C.
- the alcohol is selected from methanol, ethanol, propanol and butanol.
- the said solvent from combined extracts is removed under reduced pressure ranging from 20 to 100 PSI at temperature ranging from 35 to 65°C and the viscous residue thus obtained is called as plants extract, the plants extract is suspended in water in the ratio ranging from 20 to 70% by stirring for 10 to 50 minutes and is mixed with roasted seed powder mixture in the ratio ranging up to 20%.
- the mixture of plants extract and roasted seed powders are mixed thoroughly in a mixer grinder for a period of ranging from 5 to 50 minutes and the mixture is dried for a period of ranging from 12 to 48 hours at temperature ranging from 30 to 50°C.
- the dried plants extract and seed powders mixture is again mixed thoroughly in a mixer grinder for a period of ranging from 5 to 50 minutes and the powder thus obtained is used to prepare final nutraceuticals.
- the amount of optional additives used namely sugar/jaggary or mixture thereof, milk powder, Viper longum, Myristica fragrants, Elettaria cardamomun and coca powder are in the ranges between 23-50 % by wt, 0-30 % by wt, 0.5 -
- the optional additives present are in the ranges between sugar/jaggary 20 - 35 % by wt, milk powder 0-20 % by wt, Piper longum 0.5 -5 % by wt, Myristica fragrants 0-3 % by wt, Elettaria cardamomun 0-4 % by wt and coca powder 0-
- the dried, powdered, mixture of plants extract, roasted seed powders, sugar/jaggary, milk powder, coca powder, Elettaria cardamomum powder, Piper longum fruit powder and Myristica fragrans (Jaiphal) fruit powder mixture is mixed thoroughly in a mixer grinder for a period of ranging from 5 to 50 minutes to get the final nutraceuticals.
- nutraceutical formulations as herein described for the composition, methodology, preparation of base materials and value addition by plants extract to get the end products, may be used as health protective, promotive, food supplements to ameliorate the general health of females with optimum nutrients so as to ensure the optimal growth and development of the child both at prenatal and post natal stages.
- the novelty of present invention is the specific combination of legumes, cereals, pseudocereals fortified with herbs/ medicinal plants and the process for the preparation of nutraceuticals.
- the nutraceuticals are with optimum nutrition, non toxic, natural herbal plant products, easy to digest, have protective, preventive and health promotive properties for the best health and vigour of the females, pregnant and lactating mothers so as to ensure the optimal growth and development of the child both at prenatal and post natal stages.
- the present invention provides a process for the preparation of custom-made herbal health protective nutraceuticals.
- the present invention provides formulation for the combination of edible legumes, cereals, pseudocereals with promising potential for the development of well balanced nutritional base material.
- the present invention provides value added products with synergistic health promotive, protective and preventive effects of natural herbs/medicinal plants to get specifically designed nutraceuticals for well balanced natural nutrients, to get optimum nutrition for general health protective benefits to the females, pregnant and lactating mothers and to ward off malnutrition.
- nutraceutical formulation To prepare nutraceutical formulation the seeds of Glycine max, Cicer arietinum, Phaseolus mungo, Triticum aestivum, Hordeum vulgare, Amaranthus hypochondriacus and Fagopyrum esculantus were roasted by keeping in microwave oven for 3 minutes separately. The microwave roasted seeds, were powdered separately to pass through a 100-mesh sieve. The seed powders and herbs/medicinal plants extract were mixed as given in example 1.
- the microwave roasted seed powders of Glycine max 30g, Cicer arietinum 15g, Phaseolus mungo lOg, Triticum aestivum lOg, Hordeum vulgare lOg, Amaranthus hypochondriacus 15g and Fagopyrum esculantus lOg were mixed for 20 minutes in a mixer grinder.
- the roots, fruits, bark, whole plant of natural authentic herbs/medicinal plants collected from different natural sources in India were cut into small pieces of about 3 cm, dried under shade at 25°C, crushed and powdered to 10- mesh.
- the 10 g of plants extract was suspended in 20 ml water and mixed with mixer grinder for a period of 30 minutes, the suspension of plants extract was mixed with the 90 g mixture of roasted seed powders and mixed thoroughly for a period of 30 minutes.
- the plants extract and seed powders mixture was dried for 42 hours at 40° C, the dried plants extract and seed powders mixture was again mixed thoroughly in a mixer grinder for 25 minutes. The powder thus obtained was used to prepare final nutraceuticals.
- the 53. Og dried plants extract and seed powders mixture was mixed with 35.
- the combination of the present nutraceuticals is a mixture having synergistic health protective and promotive properties useful as food supplement for females.
- nutraceutical formulation To prepare nutraceutical formulation the seeds of Glycine max, Phaseolus vulgaris, Phaseolus radiatus, Psophocarpus tetragonolobus, Triticum aestivum, Amaranthus hypochondriacus and Chenopodium quinoa were roasted by keeping in microwave oven for 7 minutes separately. The microwave roasted seeds, were powdered separately to pass through a 200- mesh sieve. The seed powders and herbs/medicinal plants extract were mixed as given in example 2.
- Example 2 The microwave roasted seed powders of Glycine max 15g, Phaseolus vulgaris 15g, Phaseolus radiatus 20g, Psophocarpus tetragonolobus 5g, Triticum aestivum 15g, Amaranthus hypochondriacus 25g and Chenopodium quinoa 5g were mixed for 30 minutes in a mixer grinder.
- the roots, whole plant, bark, fruits of natural authentic herbs/medicinal plants collected from different natural sources in India were cut into small pieces of about 3 cm, dried under shade at 30°C, crushed and powdered to 10- mesh.
- the 12 g of plants extract was suspended in 30 ml water and mixed with mixer grinder for a period of 30 minutes, the suspension of plants extract was mixed with the 88 g mixture of roasted seed powders and mixed thoroughly for a period of 35 minutes.
- the plants extract and seed powders mixture was dried for 36 hours at 45°C, the dried plants extract and seed powder mixtures were again mixed thoroughly in a mixer grinder 35 minutes. The powder thus obtained was used to prepare final nutraceuticals.
- the 50g dried plants extract and seed powders mixture was mixed with 20g jaggary, 20g milk powder, 3.0g Piper longum (Pippali) fruit powder and 3.0g Myristica fragrans (Jaiphal) fruit powder, 4.0g Elettaria cardamomum (Elaichi) powder and the total mixture was mixed thoroughly in a mixer grinder for 30 minutes to get the final nutraceuticals.
- the combination of the legumes, cereals, pseudocereals and herbs/medicinal plants in the present investigation is a mixture having synergistic properties useful as food supplement for females, pregnant and lactating mothers for pre and post natal health protective and promotive benefits.
- nutraceutical formulation To prepare nutraceutical formulation the seeds of Glycine max, Phaseolus radiatus, Mucuna pruriens, Hordeum vulgare, Amaranthus hypochondriacus and Fagopyrum esculantus were roasted by keeping in microwave oven for 10 minutes separately. The microwave roasted seeds were powdered separately to pass through a 300-mesh sieve. The seed powders and herbs/medicinal plants were mixed as given in example 3.
- the microwave roasted seed powders of Glycine max 40g, Phaseolus radiatus lOg, Mucuna pruriens lOg, Hordeum vulgare 20g, Amaranthus hypochondriacus 15g, and Fagopyrum esculantus 5g were mixed for 25 minutes in a mixer grinder.
- the roots, fruits, whole plant of natural authentic herbs/medicinal plants collected from different natural sources in India were cut into small pieces of about 6 cm, dried under shade at 40°C, crushed and powdered to 20- mesh.
- the dried powder of Centella asiatica (Brahmi) whole plant lOOg, Pueraria tuberosa (Vidhari) roots 150g, Chlorophytum tuberosum (Safed musli) roots 50g, Boerhaavia diffusa (Punarnava) roots 150g, Sida cordifolia (Bala) roots lOOg and Asparagus racemosus (Satawari) roots 75g were mixed and extracted with 1.5 lit aqueous alcohol 70% v/v thrice for 36 hours, at 55°C, the solvent from combined extractives was removed under reduced pressure at 50 psi, temperature of 50°C and the viscous residue thus obtained was called as the plants extract.
- the 15 g of plants extract was suspended in 50 ml water and mixed with mixer grinder for a period of 35 minutes, the suspension of plants extract was mixed with the 85 g mixture of roasted seed powders and mixed thoroughly for a period of 40 minutes.
- the plants extract and seed powders mixture was dried for 28 hours at 50° C, the dried plants extract and seed powders mixture was again mixed thoroughly in a mixer grinder 45 minutes.
- the powder thus obtained was used to prepare final nutraceuticals.
- the 60 g dried plants extract and seed powders mixture was mixed with 30g pale sugar powder powder, 6.0g coca powder and 4.0g Piper longum (Pippali) fruit powder. The total mixture was mixed thoroughly in a mixer grinder for 50 minutes to get the final nutraceuticals.
- the combination of the legumes, cereals, pseudocereals and herbs/medicinal plants in the present investigation is a mixture having synergistic properties useful as food supplement for health protective and promotive benefits of the females.
- Phaseolus mungo lOg, Phaseolus radiatus 15g, Hordeum vulgare 25g, Amaranthus hypochondriacus lOg and Fagopyrum esculantus 10 g were mixed for 35 minutes in a mixer grinder.
- the whole plant, roots of natural authentic herbs/medicinal plants collected from different natural sources in India were cut into small pieces of about 7 cm, dried under shade at 40°C, crushed and powdered to 10- mesh.
- the 20 g of plants extract was suspended in 60 ml water and mixed with mixer grinder for a period of 45 minutes, the suspension of plants extract was mixed with the 80 g mixture of roasted seed powders and mixed thoroughly for a period of 45 minutes.
- the plants extract and seed powders mixture was dried for 48 hours at 50° C, the dried plants extract and seed powders mixture was again mixed thoroughly in a mixer grinder for 35 minutes.
- the powder thus obtained was used to prepare final nutraceuticals.
- the 65.0g dried herbs extract and seed powder mixture was mixed with 20g jaggary, 5.0g Piper longum (Pippali) fruit powder and lO.Og coca powder and the total mixture was mixed thoroughly in a grinder mixture for 40 minutes to get the final nutraceuticals.
- the combination of the present nutraceuticals have synergistic health protective and promotive properties useful as food supplement for females, pregnant and lactating mothers.
- Table 1 The amount (% composition) of seed powders (legumes, cereals & pseudocereals) in the base products.
- Table 2 The amount (%) of different herbs/medicinal plants in the total used for extraction with alcohol.
- Table 3 The percent composition & ratio of the seed powders and Herbs/Plants extract 10-20 g (10, 12, 15 and 20 g) of the extract was mixed with 80-90g of the base products (90, 88, 85 and 80 g mixture of the seed powders in examples 1, 2, 3 and 4 respectively).
- Table 5 Record of Clinical Trial & Feed Back from Volunteers after consuming the Herbal Health Protective and Promotive Nutraceuticals for Females / Expectant mothers
- Age group 20 - 50 years
- Product 1-9 Base (Seed powders mixture) + Extract of single plant or different combinations of herbs/medicinal plants Nutrition Composition of Commercially Available Samples: 1. BOURNVITA:
- Protein V g 40 Helps to build muscle tissues
- Vitamin B 6 0.76 mg
- Vitamin B I2 0.76 mg
- Vitamin K 3 0.13 mg; Iron-gluconate 17 mg; Niacinamide 15 mg; Pantothenate 1.0 mg; Folic acid 50 Meg ; Biotin 10 mg
- Fatless milk solid Fatless milk solid, wheat flour, sucrose, edible vegetable oil, vitamins & minerals.
- Age group 20 - 50 years
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Pediatric Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Medical Informatics (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cereal-Derived Products (AREA)
- Seeds, Soups, And Other Foods (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB018236812A CN100521969C (zh) | 2001-08-30 | 2001-08-30 | 用于妇女/孕妇的草药营养药制剂及其制备方法 |
EP01963364A EP1420657A1 (fr) | 2001-08-30 | 2001-08-30 | Composition nutraceutique a base d'herbes destinee aux femmes/femmes enceintes et son procede de preparation |
JP2003522317A JP2005500074A (ja) | 2001-08-30 | 2001-08-30 | 女性/妊婦用の薬草由来の栄養補助製剤およびその調製方法 |
KR1020047003064A KR100855376B1 (ko) | 2001-08-30 | 2001-08-30 | 여성 및 임산부를 위한 허브 기능식품 제제 및 이의 제조방법 |
PCT/IN2001/000151 WO2003017784A1 (fr) | 2001-08-30 | 2001-08-30 | Composition nutraceutique a base d'herbes destinee aux femmes/femmes enceintes et son procede de preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2001/000151 WO2003017784A1 (fr) | 2001-08-30 | 2001-08-30 | Composition nutraceutique a base d'herbes destinee aux femmes/femmes enceintes et son procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003017784A1 true WO2003017784A1 (fr) | 2003-03-06 |
Family
ID=11076374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2001/000151 WO2003017784A1 (fr) | 2001-08-30 | 2001-08-30 | Composition nutraceutique a base d'herbes destinee aux femmes/femmes enceintes et son procede de preparation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1420657A1 (fr) |
JP (1) | JP2005500074A (fr) |
KR (1) | KR100855376B1 (fr) |
CN (1) | CN100521969C (fr) |
WO (1) | WO2003017784A1 (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004056382A1 (fr) * | 2002-12-20 | 2004-07-08 | Council Of Scientific And Industrial Research | Boisson sans alcool a base d'herbes ayurvediques |
GB2412834A (en) * | 2004-04-07 | 2005-10-12 | International Ltd Valid | A ready-to-use nutritional supplement |
WO2005074958A3 (fr) * | 2004-01-09 | 2006-04-06 | Council Scient Ind Res | Procede pour augmenter la phosphorylation et la translocation de glut4 afin d'augmenter le signal de l'insuline |
WO2006053379A1 (fr) * | 2004-11-16 | 2006-05-26 | Universal Food Solutions Pty Ltd | Formule améliorée de produit nutraceutique |
WO2006061849A1 (fr) * | 2004-12-10 | 2006-06-15 | Council Of Scientific And Industrial Research | Nouveaux aliments fonctionnels favorables a la sante renforces en herbes medicinales |
WO2009023918A1 (fr) * | 2007-08-20 | 2009-02-26 | Quinn Pharmaceuticals | Procédé de production de formulations d'extraits de plantes |
US8142800B1 (en) * | 2001-12-18 | 2012-03-27 | Tamea Rae Sisco | Oral high potency clinical anti-craving treatment and method of use |
WO2020031209A1 (fr) * | 2018-08-09 | 2020-02-13 | Sushil Kumar | Procédé de préparation d'un complément alimentaire et formulation associée |
JP2021119754A (ja) * | 2020-01-30 | 2021-08-19 | フジッコ株式会社 | L−ドーパを含有する豆類の加工方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5159568B2 (ja) * | 2008-11-07 | 2013-03-06 | 小林製薬株式会社 | ヒハツ抽出物を含有する飲食品組成物及びヒハツ抽出物含有飲食品組成物の味改善方法 |
FR2948537B1 (fr) * | 2009-07-29 | 2011-09-09 | France Bebe Nutrition Lab | Composition nutritive pour femmes allaitant |
KR101505576B1 (ko) * | 2014-08-08 | 2015-03-25 | 주식회사 코씨드바이오팜 | 아스파라거스 추출물을 함유하는 팽창선조 예방 또는 개선용 조성물 |
JP7043708B2 (ja) * | 2017-11-29 | 2022-03-30 | 株式会社デザインサプリ | サプリメント推奨システム |
CN108851079A (zh) * | 2018-08-27 | 2018-11-23 | 陕西鹤鸣健康科技有限公司 | 一种促进生长发育的复方制剂及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2714573A1 (fr) * | 1993-12-31 | 1995-07-07 | Inst Rech Biolog Sa | Nouveau complément nutritionnel à base d'oléagineux et procédé d'obtention. |
GB2304050A (en) * | 1992-11-26 | 1997-03-12 | Eladevi Shah | Herbal compositions |
AU7190496A (en) * | 1995-11-21 | 1997-05-29 | New Chapter IP Pty Ltd | Therapeutic compositions |
EP0890360A1 (fr) * | 1997-04-21 | 1999-01-13 | Dabur Research Foundation | Compositions pharmaceutiques à base de plantes utiles pour le traitement de conditions associés avec les infections virales de l'hépatite E et l'hépatite B |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2747206B2 (ja) * | 1993-11-12 | 1998-05-06 | 神協産業株式会社 | 高血糖改善用組成物 |
JPH07157420A (ja) * | 1993-12-01 | 1995-06-20 | Mikimoto Pharmaceut Co Ltd | 化粧品 |
JPH07163303A (ja) * | 1993-12-15 | 1995-06-27 | Takano Co Ltd | 食品添加物及びその製造方法 |
JPH08310949A (ja) * | 1995-05-19 | 1996-11-26 | Yakult Honsha Co Ltd | アシルコエンザイムa:コレステロールアシルトランスフェラーゼ阻害剤 |
JPH1099047A (ja) * | 1996-10-01 | 1998-04-21 | Sachira:Kk | 健康食品 |
JP3925828B2 (ja) * | 1999-04-22 | 2007-06-06 | キッコーマン株式会社 | アクテオシドの抽出法 |
-
2001
- 2001-08-30 KR KR1020047003064A patent/KR100855376B1/ko not_active Expired - Fee Related
- 2001-08-30 WO PCT/IN2001/000151 patent/WO2003017784A1/fr not_active Application Discontinuation
- 2001-08-30 EP EP01963364A patent/EP1420657A1/fr not_active Withdrawn
- 2001-08-30 JP JP2003522317A patent/JP2005500074A/ja active Pending
- 2001-08-30 CN CNB018236812A patent/CN100521969C/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2304050A (en) * | 1992-11-26 | 1997-03-12 | Eladevi Shah | Herbal compositions |
FR2714573A1 (fr) * | 1993-12-31 | 1995-07-07 | Inst Rech Biolog Sa | Nouveau complément nutritionnel à base d'oléagineux et procédé d'obtention. |
AU7190496A (en) * | 1995-11-21 | 1997-05-29 | New Chapter IP Pty Ltd | Therapeutic compositions |
EP0890360A1 (fr) * | 1997-04-21 | 1999-01-13 | Dabur Research Foundation | Compositions pharmaceutiques à base de plantes utiles pour le traitement de conditions associés avec les infections virales de l'hépatite E et l'hépatite B |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Section Ch Week 199730, Derwent World Patents Index; Class B05, AN 1997-320130, XP002200189 * |
G.C. SMITH ET AL: "Mineral values of selected plant foods common to southern Burkina Faso and to Niamey, Niger, West Africa", INT. J. OF FOOD SCIENCES AND NUTRITION, vol. 47, 1996, pages 41 - 53, XP008003767 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8142800B1 (en) * | 2001-12-18 | 2012-03-27 | Tamea Rae Sisco | Oral high potency clinical anti-craving treatment and method of use |
WO2004056382A1 (fr) * | 2002-12-20 | 2004-07-08 | Council Of Scientific And Industrial Research | Boisson sans alcool a base d'herbes ayurvediques |
US7550163B2 (en) | 2002-12-20 | 2009-06-23 | Council Of Scientific And Industrial Research | Herbal soft drink |
WO2005074958A3 (fr) * | 2004-01-09 | 2006-04-06 | Council Scient Ind Res | Procede pour augmenter la phosphorylation et la translocation de glut4 afin d'augmenter le signal de l'insuline |
GB2412834A (en) * | 2004-04-07 | 2005-10-12 | International Ltd Valid | A ready-to-use nutritional supplement |
WO2006053379A1 (fr) * | 2004-11-16 | 2006-05-26 | Universal Food Solutions Pty Ltd | Formule améliorée de produit nutraceutique |
WO2006061849A1 (fr) * | 2004-12-10 | 2006-06-15 | Council Of Scientific And Industrial Research | Nouveaux aliments fonctionnels favorables a la sante renforces en herbes medicinales |
WO2009023918A1 (fr) * | 2007-08-20 | 2009-02-26 | Quinn Pharmaceuticals | Procédé de production de formulations d'extraits de plantes |
WO2020031209A1 (fr) * | 2018-08-09 | 2020-02-13 | Sushil Kumar | Procédé de préparation d'un complément alimentaire et formulation associée |
JP2021119754A (ja) * | 2020-01-30 | 2021-08-19 | フジッコ株式会社 | L−ドーパを含有する豆類の加工方法 |
JP7282047B2 (ja) | 2020-01-30 | 2023-05-26 | フジッコ株式会社 | L-ドーパを含有する豆類の加工方法 |
Also Published As
Publication number | Publication date |
---|---|
EP1420657A1 (fr) | 2004-05-26 |
JP2005500074A (ja) | 2005-01-06 |
KR20040111326A (ko) | 2004-12-31 |
KR100855376B1 (ko) | 2008-09-04 |
CN1558724A (zh) | 2004-12-29 |
CN100521969C (zh) | 2009-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6881425B2 (en) | Custom made herbal health promotive formulation for females/expectant mothers | |
US7014872B2 (en) | Herbal nutraceutical formulation for diabetics and process for preparing the same | |
CN108835628B (zh) | 减肥代餐粉及其制备方法 | |
KR0126431B1 (ko) | 혈당강하 효과가 있는 건강식품 조성물 | |
WO2004016092A1 (fr) | Poudre ou extraits de feuilles vegetales presentant des effets anti-obesite et aliments anti-obesite comprenant ceux-ci | |
CN100521969C (zh) | 用于妇女/孕妇的草药营养药制剂及其制备方法 | |
WO2006137635A1 (fr) | Lait sous forme de comprime comportant une substance antioxydante et son procede de fabrication | |
US20110020285A1 (en) | Composition Containing Cacao and Spirulina | |
JP2010265251A (ja) | 血流促進改善剤 | |
KR20160032851A (ko) | 흰점박이 꽃무지를 주재료로 하는 환의 제조방법 | |
KR20100109697A (ko) | 체중감량 및 고지혈증 개선 효과가 있는 기능성 조성물 | |
KR20040095949A (ko) | 식물잎을 포함하는 비만 억제용 조성물 | |
KR100549193B1 (ko) | 인삼 및 폴리페놀계 물질 또는 바이오플라보노이드계 물질을 포함하는 식물의 분말 또는 추출물을 포함하는 항비만용 식품 | |
CN113841884A (zh) | 改善营养代谢的速溶代餐粉配方及其制作方法 | |
JP2006045212A (ja) | 特定のキナ酸誘導体を含有する経口用組成物 | |
WO2019092738A1 (fr) | Ingrédient constitué de fibre alimentaire insoluble amélioré | |
KR100503208B1 (ko) | 다이어트 식품 조성물 | |
KR20040070112A (ko) | 인삼가공절편이 포함된 선식의 조성물 및 이를 이용한다이어트 선식 조성물 | |
Ashok et al. | Nutraceutical values of minor fruits on immunity development to combat diseases | |
RU2458538C1 (ru) | Продукт диетического, профилактического и функционального питания для спортивного питания с пробиотиком в | |
KR20160079685A (ko) | 건강환 및 이의 제조방법 | |
KR20050047053A (ko) | 현미 및 각종영양재료를 주제로한 식사대용식품 | |
KR102539641B1 (ko) | 천연 산야초를 이용한 칼국수와 그의 제조방법 | |
CN103636791A (zh) | 不上火的健康奶粉 | |
KR102082115B1 (ko) | 굼벵이를 이용한 건강식품의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ PH PL PT RO SD SE SG SI SK SL TJ TM TR TT TZ UG US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZW AM AZ BY KG KZ MD TJ TM AT BE CH CY DE DK ES FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW MR NE SN TD TG Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 328/DELNP/2004 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003522317 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020047003064 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001963364 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20018236812 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2001963364 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001963364 Country of ref document: EP |